Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Stoke Therapeutics, Inc. (0GT.F)

Compare
5.70
-0.10
(-1.72%)
As of 8:19:55 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
36,555
36,555
8,780
12,405
--
Operating Expense
137,927
137,927
123,553
116,761
86,065
Operating Income
-101,372
-101,372
-114,773
-104,356
-86,065
Net Non Operating Interest Income Expense
12,638
12,638
9,908
3,122
120
Other Income Expense
-247
-247
166
167
140
Pretax Income
-88,981
-88,981
-104,699
-101,067
-85,805
Net Income Common Stockholders
-88,981
-88,981
-104,699
-101,067
-85,805
Diluted NI Available to Com Stockholders
-88,981
-88,981
-104,699
-101,067
-85,805
Basic EPS
-2.08
-1.65
-2.38
-2.60
-2.34
Diluted EPS
-2.08
-1.65
-2.38
-2.60
-2.34
Basic Average Shares
50,985.63
54,008.88
43,994.86
38,897.44
36,739.27
Diluted Average Shares
50,985.63
54,008.88
43,994.86
38,897.44
36,739.27
Total Operating Income as Reported
-101,372
-101,372
-114,773
-104,356
-86,065
Total Expenses
137,927
137,927
123,553
116,761
86,065
Net Income from Continuing & Discontinued Operation
-88,981
-88,981
-104,699
-101,067
-85,805
Normalized Income
-88,981
-88,981
-104,699
-101,067
-85,805
Interest Income
--
--
--
--
120
Net Interest Income
12,638
12,638
9,908
3,122
120
EBIT
-101,372
-101,372
-114,773
-104,356
-86,065
EBITDA
-99,195
-99,195
-112,304
-102,810
-85,091
Reconciled Depreciation
2,177
2,177
2,469
1,546
974
Net Income from Continuing Operation Net Minority Interest
-88,981
-88,981
-104,699
-101,067
-85,805
Normalized EBITDA
-99,195
-99,195
-112,304
-102,810
-85,091
12/31/2021 - 8/16/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade